Navigation Links
2011 CTRC-AACR San Antonio Breast Cancer Symposium to focus on new treatments and prevention

SAN ANTONIO Now in its 34th year, the 2011 CTRC-AACR San Antonio Breast Cancer Symposium will focus on emerging treatments in hard-to-treat populations, including patients with metastatic breast cancer, and on new knowledge about prevention and risk.

The symposium will be held at the Henry B. Gonzales Convention Center in San Antonio during Dec. 6-10, 2011.

The symposium is presented by the Cancer Therapy & Research Center at University of Texas Health Science Center at San Antonio, the American Association for Cancer Research and Baylor College of Medicine. The driving force behind this collaboration is the shared mission of the organizations to advance progress in breast cancer research.

To help guide coverage for the news media, the AACR Office of Communications will operate a full-service press room in Room 217A-C of the convention center.

New research will be presented during the following five press conferences held in Room 217D. Reporters who cannot attend in person can call in using the following information:

  • U.S./Canada (Toll Free): 1 (888) 647-7462
  • International (Toll): 1 (201) 604-0169

The meeting will open with a press conference on Wednesday, Dec. 7, 2011, at 7:30 a.m. CT, hosted by Jennifer Ligibel, M.D., a breast oncologist and assistant professor of medicine at the Dana-Farber Cancer Institute. The press conference will focus on the following research:

  • Diabetes and Obesity Increase Risk for Breast Cancer Development
  • Molecular Differences May Be Used to Predict Early vs. Late Hormone Receptor-Positive Breast Cancer Recurrence
  • Brachytherapy Was Associated With Twofold Increased Risk for Mastectomy, Complications
  • New Test Predicts Risk for Recurrence for Patients With DCIS

Later that afternoon, at 12:30 p.m. CT, the Institute of Medicine will present a report entitled, "Breast Cancer and the Environment: A Life Course Approach." More information can be found here.

Finally, at 5:00 p.m. CT, James Ingle, M.D., professor of oncology at the Mayo Clinic in Rochester, will host a media availability on important new research in bisphosphonates and breast cancer, which will feature the following research:

  • Zoledronic Acid Shows Long-Term Benefit in Survivorship for Premenopausal ER-Positive Breast Cancer
  • Clodronate Appeared Safe, Modestly Affected Breast Cancer Disease Events
  • Immediate Bisphosphonate Use With Endocrine Therapy Reduced Recurrence, Increased Survival in Postmenopausal Early Breast Cancer
  • Oral Bisphosphonate Did Not Improve Prognosis for Patients With Breast Cancer

On Thursday, Dec. 8, 2011, at 7:30 a.m. CT, Lisa A. Carey, M.D., Preyer distinguished professor in breast cancer research at the University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, will host a press conference featuring late-stage clinical trials in hard-to-treat populations. The press conference will feature the following research:

  • Dual HER2 Blockade Significantly Extends Progression-Free Survival
  • Exemestane Plus Everolimus Increased Progression-Free Survival for Women With Metastatic Breast Cancer
  • Addition of Bevacizumab to Conventional Therapy Improved Progression-Free Survival in HER2-Positive Breast Cancer

At 12:30 p.m. CT, on Thursday, Dec. 8, 2011, Patricia Ganz, M.D., professor at the UCLA Schools of Medicine and Public Health and director of the division of cancer prevention and control research at the Jonsson Comprehensive Cancer Center, will host a press conference on issues in genetics and socioeconomics that will feature the following research:

  • Risk for Developing New Cancer in Other Breast Increased for Survivors With BRCA Mutation
  • Many Women Do Not Undergo Breast Reconstruction After Mastectomy
  • Bilateral Oophorectomy Associated With Higher Prevalence of Low Bone Mineral Density and Arthritis in Younger Women

In addition to the press conferences, the 2011 CTRC-AACR San Antonio Breast Cancer Symposium has identified the following research as newsworthy:

  • Starch Intake May Influence Risk for Breast Cancer Recurrence
  • Intermittent, Low-Carbohydrate Diets More Successful Than Standard Dieting, Present Possible Intervention for Breast Cancer Prevention
  • Addition of Trastuzumab May Potentially Equalize Disease-Free Survival Outcomes Among Obese and Normal-Weight Patients
  • MRI May Be Noninvasive Method to Measure Breast Cancer Prognosis
  • Obesity Linked to Worse Outcomes in Early Breast Cancer Treatment
  • Breast Cancer Mortality Higher in Hispanic Women


Contact: Jeremy Moore
American Association for Cancer Research

Related medicine news :

1. Cancer research presented at 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium
2. San Antonio Business Journal Names BMI of Texas One of the Best Places to Work in San Antonio
3. BMI of Texas Offers Free Educational Seminars in San Antonio for People Considering Weight Loss Surgery
4. San Antonio Chamber Honors Women Business, Community Leaders
5. VA Announces $41 Million in Construction Contracts for San Antonio
6. First whole-genome sequencing clinical trials for triple-negative breast cancer presented
7. Lobular Breast Cancer Linked to Paternal Cancer History
8. Gene acts as a brake on breast cancer progression
9. New study shows biopsy of recurrent breast cancer can alter treatment
10. Older Women Have More Post-Surgical Breast Reduction Infections
11. Breast cancer type linked to paternal cancer
Post Your Comments:
(Date:12/1/2015)... CA (PRWEB) , ... December 01, 2015 , ... ... and clinical solutions for the care management and population health arenas, is pleased ... providing clinical and cost containment services, has successfully implemented the ACUITY Complete Care™ ...
(Date:12/1/2015)... ... December 01, 2015 , ... With FCPX Overlay: Grit , ... control over customization, the possibilities are truly endless, all with a click of a ... position, vertical flip, horizontal flip, depth of field and more, all within Final Cut ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes Tympani as ... Cisco Unified Contact Center solutions targeted to the high-end enterprise contact center marketplace. ...
(Date:11/30/2015)... Caicos Islands, BWI (PRWEB) , ... December 01, 2015 , ... ... Recently Caribbean Journal, one of the leading digital news sites highlighting Caribbean destinations, ... reason? The weather. While much of North America shivers under chilly grey skies ...
(Date:11/30/2015)... ... November 30, 2015 , ... 1Heart ... Convention of the Federation of Philippine American Chambers of Commerce held from November ... , 1Heart Caregiver Services, as an active delegate from the Philippine American ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 01, 2015 ... the "Veterinary Equipment and Disposables Market by ... report to their offering. --> ... "Veterinary Equipment and Disposables Market by product, ... report to their offering. --> Research ...
(Date:12/1/2015)... 2015   MabVax Therapeutics Holdings, Inc . (OTCQB: ... has filed an Investigational New Drug Application (IND) with ... Company,s lead fully human antibody product HuMab 5B1 as ... to initiate the Phase I clinical trial early in ... The planned Phase I trial will evaluate the ...
(Date:12/1/2015)... BOSTON , Dec. 1, 2015  The ... (HCOs) to develop shared care plans that help ... These care plans will be digitally enabled, incorporate ... unique needs and desires. They will also allow ... a patient,s health journey is optimal. That is ...
Breaking Medicine Technology: